Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$19,466,367
+$2,849,262 QoQ
Shares Held
77,358
+1.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#621
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meridian Wealth Management, LLC holds $80,207,351 across 13 Drug Manufacturers - General names. ABBV ranks #1 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
77,358 | $19,466,367 | |
| 2 | LLY |
ELI LILLY & Co
|
15,030 | $18,027,434 | |
| 3 | JNJ |
Johnson & Johnson
|
53,587 | $13,609,490 | |
| 4 | MRK |
Merck & Co., Inc.
|
79,604 | $10,229,114 | |
| 5 | AMGN |
Amgen Inc
|
14,339 | $5,192,438 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
40,890 | $5,166,042 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
52,891 | $3,047,579 | |
| 8 | PFE |
Pfizer Inc
|
103,774 | $2,498,877 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,466,367 | 77,358 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $16,617,105 | 76,404 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $17,181,991 | 75,198 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $17,515,537 | 75,648 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $14,249,304 | 76,766 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $16,304,636 | 77,819 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $12,845,755 | 72,289 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $14,786,907 | 74,878 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $12,437,772 | 72,515 | Shares | Sole | 2024-08-08 | |
| 2023-12-31 | $11,077,410 | 71,481 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $6,929,054 | 46,485 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $5,799,587 | 43,046 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $6,868,368 | 43,097 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,150,230 | 38,056 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,251,368 | 39,128 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,269,451 | 40,934 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $7,156,832 | 44,148 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,346,333 | 46,871 | Shares | Other | 2022-01-27 | |
| 2021-09-30 | $4,832,791 | 44,802 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $4,511,344 | 40,051 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $3,782,505 | 34,952 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $4,321,252 | 40,329 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $3,301,617 | 37,694 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $2,552,189 | 25,995 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $1,935,911 | 25,409 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||